| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 47.4% | 9/19 |
| Female | 52.6% | 10/19 |
| Indifferent | 0% | 0/19 |
| Unknown | 0% | 0/19 |
| General | ||
| 5.3% | 1/19 | |
| Birth Weight | 0% | 0/19 |
| 10.5% | 2/19 | |
| 31.6% | 6/19 | |
| 5.3% | 1/19 | |
| 36.8% | 7/19 | |
| 84.2% | 16/19 | |
| 78.9% | 15/19 | |
| 78.9% | 15/19 | |
| 80% | 12/15 | |
| Neurology | ||
| 73.7% | 14/19 | |
| 31.6% | 6/19 | |
| 26.3% | 5/19 | |
| Facial abnormalities | ||
| 31.6% | 6/19 | |
| 94.7% | 18/19 | |
| 26.3% | 5/19 | |
| 94.7% | 18/19 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/19 |
| 63.2% | 12/19 | |
| Heart | ||
| 10.5% | 2/19 | |
| Pulmonary | ||
| 10.5% | 2/19 | |
| Gastrointestinal | ||
| 42.1% | 8/19 | |
| Urogenital | ||
| Urogenital | 0% | 0/19 |
| Skeleton | ||
| 94.7% | 18/19 | |
| Skin / Hair / Nails | ||
| 15.8% | 3/19 | |
| Endocrine / Immunological / Metabolic | ||
| 5.3% | 1/19 | |
| Metabolic | 0% | 0/19 |
| Immune | 0% | 0/19 |
| Neoplasia | ||
| Neoplasia | 0% | 0/19 |
| Inheritance | ||
| 100% | 19/19 | |
BRPF1